Others may react with headaches, fatigue, or respiratory symptoms
Here is where retatrutide and tirzepatide diverge in ways that matter
Scott Isaacs, MD, FACP, FACEs Post This NEJM Perspective highlights a growing problem with GLP-1 therapy: rising off-label, lifestyle use, little eating-disorder screening, and millions at risk of silent harm if we do not build safeguards now
The FDA's approval of semaglutide ensures that patients receive a medication manufactured in a controlled environment, minimizing the risks associated with variability and contamination
These are laboratory research observations only, are not established human or veterinary effects, and no combined effect is claimed
910 Mitochondrial impairment serves as an important biomarker for a range of conditions, including neurological, cardiovascular, infectious, cancerous, and metabolic disorders